All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| CHEBI_21078 | CHEBI_21078 | |
| 2-[[6-[(3-bromo-6-oxo-1-cyclohexa-2,4-dienylidene)methylamino]-1,3-benzothiazol-2-yl]thio]-N-phenylacetamide | CHEBI_94034 | |
| CHEBI_21079 | CHEBI_21079 | |
| valproate | CHEBI_60654 | [A branched-chain saturated fatty acid anion that is the conjugate base of valproic acid.] |
| branched-chain saturated fatty acid anion | CHEBI_58956 | [Any saturated fatty acid anion with a carbon side-chain or isopropyl termination.] |
| antimanic drug | CHEBI_35477 | [Antimanic drugs are agents used to treat bipolar disorders or mania associated with other affective disorders.] |
| (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol | CHEBI_94035 | |
| 6-methoxy-2-octaprenylhydroquinone | CHEBI_60655 | [A polyprenylhydroquinone in which the polyprenyl substituent is octaprenyl at C-2; a methoxy group is also present at C-6.] |
| 5-methoxy-2-methyl-3-octaprenylhydroquinone | CHEBI_60656 | [A polyprenylhydroquinone in which the polyprenyl substituent is octaprenyl at C-3; methoxy and methyl groups are also present at C-5 and C-2 respectively.] |
| 1,2-di-O-arachidonoyl-sn-glycero-3-phosphocholine | CHEBI_60657 | [A 1,2-diacyl-sn-glycero-3-phosphocholine in which the phosphatidyl acyl groups at positions 1 and 2 are both arachidonoyl.] |
| 2-methyl-5-[(2-methyl-4-quinolinyl)thio]-1,3,4-thiadiazole | CHEBI_94030 | |
| 4-[(1,3-dioxo-5-benzo[de]isoquinolinyl)sulfonylamino]benzoic acid | CHEBI_94031 | |
| 5-bromo-2-[[2-(4-tert-butylphenoxy)-1-oxoethyl]amino]benzoic acid methyl ester | CHEBI_94036 | |
| N-(2-methyl-1,3-dioxo-5-isoindolyl)-1-naphthalenecarboxamide | CHEBI_94037 | |
| trimethyl-[(5-methyl-2-furanyl)methyl]ammonium | CHEBI_94038 | |
| alpha-D-Abep-(1->3)-alpha-D-Manp-(1->4)-alpha-L-Rhap | CHEBI_60650 | [A linear trisaccharide, which forms part of the repeating unit of the Salmonella serogroup B oligosaccharide.] |
| N-(3-bromophenyl)-2-[[5-(7-methoxy-2-benzofuranyl)-4-methyl-1,2,4-triazol-3-yl]thio]acetamide | CHEBI_94039 | |
| doxycycline monohydrate | CHEBI_60648 | [The monohydrate form of doxycycline. A semi-synthetic tetracycline antibiotic, it is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with chronic obstructive pulmonary disease (COPD), and adult periodontitis.] |
| doxycycline | CHEBI_50845 | [Tetracycline in which the 5beta-hydrogen is replaced by a hydroxy group, while the 6alpha-hydroxy group is replaced by hydrogen. A semi-synthetic tetracycline antibiotic, it is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with chronic obstructive pulmonary disease (COPD), and adult periodontitis.] |
| glucagon receptor antagonist | CHEBI_60649 | [An agent which blocks glucagon receptors.] |